iSonea wins Frost innovation award
21 August, 2013 by Dylan Bushell-EmblingFrost & Sullivan has handed iSonea (ASX:ISN) an Innovation Leadership Award for its AsthmaSense cloud mobile health-monitoring technology.
Nominations invited for 2013 Industry Excellence Awards
20 August, 2013Janssen and AusBiotech are delighted to announce that the Janssen 2013 Industry Excellence Awards are now open for nominations. The awards, which have three categories, will be announced at AusBiotech 2013 in Brisbane on 30 October.
Prime Minister announces Medical Technologies Innovation Partnership
19 August, 2013Prime Minister Kevin Rudd last week announced the Medical Technologies Innovation Partnership - the first of the Australian Innovation Partnership program. The program is intended to create partnerships between government, business and the research community that will create new high-skill jobs for the future.
Consultation on cost recovery for gene technology regulator
15 August, 2013The Department of Health and Ageing (DoHA) is undertaking an assessment and development of a cost recovery model for services provided by the Office of the Gene Technology Regulator (OGTR). DoHA has engaged PricewaterhouseCoopers (PwC) to undertake an economic analysis of the gene technology sector, and PwC is seeking input from sector stakeholders through the stakeholder survey.
MDI achieves goals with Penthrox trial
14 August, 2013 by Dylan Bushell-EmblingMedical Developments International (ASX:MVP) said a safety study of its Penthrox inhaler uncovered no safety concerns associated with a single supratherapeutic dose.
CSL boosts FY13 profit by 19%
14 August, 2013 by Dylan Bushell-EmblingCSL (ASX:CSL) recorded 19% higher profit for FY13 as well as 7% higher revenue, and has announced the appointment of a new director.
Ita Buttrose to speak on philanthropy for research
13 August, 2013Legendary media editor, businesswoman and 2013 Australian of the Year Ita Buttrose will be the guest dinner speaker at next week’s Research Australia 2013 Philanthropy for Health and Medical Research conference.
Cochlear FY13 profit recovers after recall
12 August, 2013 by Dylan Bushell-EmblingCochlear Limited (ASX:COH) reported a net profit for FY13 of $132.6m - up 133% year on year, but down 16% when excluding the costs of a product recall in FY12.
Nexvet appoints VP of operations
12 August, 2013 by Dylan Bushell-EmblingIP law expert Geraldine Farrell will join Melbourne-based Nexvet as the company’s VP of operations and general counsel.
Viralytics commences trading on OTCQX
12 August, 2013 by Dylan Bushell-EmblingViralytics (ASX:VLA) ADRs are now being traded on the US-based OTCQX International marketplace.
Victorian young technology entrepreneur challenge
08 August, 2013An opportunity to develop business skills exists for emerging medical device and diagnostics entrepreneurs in Victoria.
Dr Rathjen elected Pharmaceuticals Industry Council Chair
08 August, 2013Dr Deborah Rathjen, Managing Director of Bionomics and Chair of AusBiotech, has been elected as the Chair of the Pharmaceuticals Industry Council (PIC). Dr Rathjen will hold this position until at least June 2014.
Novogen names first member of advisory board
07 August, 2013 by Dylan Bushell-EmblingNovogen (ASX:NRT) has appointed Paul de Souza as chairman of its medical advisory board, which will help the company conduct clinical trials for ovarian cancer drug CS-6.
Prana hiring to help bring PBT2 to market
06 August, 2013 by Dylan Bushell-EmblingPrana Biotechnology (ASX:PBT) has hired former Alchemia CEO Dr Peter Smith to help guide late-stage development of PBT2 in Alzheimer’s and Huntington’s diseases.
iSonea gets TGA listing for AirSonea
06 August, 2013 by Dylan Bushell-EmblingiSonea (ASX:ISN) has secured an ARTG listing for wheeze-monitoring device AirSonea, paving the way for the Australian launch of the product in September.
